These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32840016)

  • 1. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.
    Tserga E; Moreno-Paublete R; Sarlus H; Björn E; Guimaraes E; Göritz C; Cederroth CR; Canlon B
    FASEB J; 2020 Oct; 34(10):13978-13992. PubMed ID: 32840016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory synaptopathy in mice lacking the glutamate transporter GLAST and its impact on brain activity.
    Tserga E; Damberg P; Canlon B; Cederroth CR
    Prog Brain Res; 2021; 262():245-261. PubMed ID: 33931183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cochlear toxicity in response to chronic 3,3'-iminodipropionitrile in mice reveals early and reversible functional loss that precedes overt histopathology.
    Greguske EA; Llorens J; Pyott SJ
    Arch Toxicol; 2021 Mar; 95(3):1003-1021. PubMed ID: 33495873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotolerance for cisplatin ototoxicity in the rat.
    Bielefeld EC; Markle A; DeBacker JR; Harrison RT
    Hear Res; 2018 Dec; 370():16-21. PubMed ID: 30253329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
    Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
    Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
    J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
    Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
    Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional roles of high-affinity glutamate transporters in cochlear afferent synaptic transmission in the mouse.
    Chen Z; Kujawa SG; Sewell WF
    J Neurophysiol; 2010 May; 103(5):2581-6. PubMed ID: 20220082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
    Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
    J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
    Li Y; Ding D; Jiang H; Fu Y; Salvi R
    Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating the unfolded protein response with ISRIB mitigates cisplatin ototoxicity.
    Li J; Rouse SL; Matthews IR; Park Y; Eltawil Y; Sherr EH; Chan DK
    Sci Rep; 2024 Sep; 14(1):22382. PubMed ID: 39333235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
    Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
    Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.
    Maruyama A; Kawashima Y; Fukunaga Y; Makabe A; Nishio A; Tsutsumi T
    Hear Res; 2024 Jun; 447():109013. PubMed ID: 38718672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of adenosine receptors in the cochlea by cisplatin.
    Ford MS; Nie Z; Whitworth C; Rybak LP; Ramkumar V
    Hear Res; 1997 Sep; 111(1-2):143-52. PubMed ID: 9307320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study.
    Tanyeli TT; Karadaş H; Akyıldız İ; Gökdoğan O; Sönmez Ç; Çavuş ME; Kaptan Z; Uzunkulaoğlu H; Arslan N; Zeybek ND
    J Int Adv Otol; 2019 Aug; 15(2):237-246. PubMed ID: 31347504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity.
    Chen Y; Bielefeld EC; Mellott JG; Wang W; Mafi AM; Yamoah EN; Bao J
    J Assoc Res Otolaryngol; 2021 Apr; 22(2):107-126. PubMed ID: 33415542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental topical ototoxicity investigations: can we underestimate unilateral ototoxicity because of cross-hearing?
    Ikiz AO
    Otolaryngol Head Neck Surg; 2000 May; 122(5):779-80. PubMed ID: 10793371
    [No Abstract]   [Full Text] [Related]  

  • 20. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW; Kaltenbach JA; Blakley BW; Burgio DL
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.